{"title":"Improving the efficiency of quality control in clinical laboratory with an integrated PBRTQC system based on patient risk.","authors":"Xincen Duan, Tony Badrick, Wenqi Shao, Andreas Bietenbeck, Xiao Tan, Jing Zhu, Wenhai Jiang, Ying Zhao, Chunyan Zhang, Baishen Pan, Beili Wang, Wei Guo","doi":"10.1515/cclm-2025-0163","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Recent advances in information technology have renewed interest in patient-based real-time quality control (PBRTQC) as an alternative to internal quality control (IQC). However, since regulations mandate IQC, PBRTQC can only be implemented as a separate system. The additional labor required for PBRTQC may hinder widespread adoption. Therefore, a more efficient system that integrates IQC with PBRTQC is needed for laboratories to implement the methods effectively.</p><p><strong>Methods: </strong>A QC system that integrates IQC with PBRTQC is proposed. The maximum average number of patients with unacceptable analytical errors (MaxANP<sub>TE</sub>) was introduced as a critical metric to benchmark the efficiency of the integrated PBRTQC system against the IQC-only system using a modified Parvin patient risk model. With the historical data of serum sodium (Na), chloride (Cl), alanine aminotransferase (ALT), and creatinine (CREA) from Zhongshan Hospital, Fudan University, in 2019, the integrated system incorporating the simple PBRTQC model and the more advanced regression-adjusted real-time quality control (RARTQC) were compared with the IQC-only system.</p><p><strong>Results: </strong>In most cases, the integrated system incorporating RARTQC models outperformed the IQC-only system, particularly for ALT, where QC events were reduced by up to 45 %. Based on these findings, we proposed strategies for laboratories to design the integrated system.</p><p><strong>Conclusions: </strong>The study demonstrated the improvement of efficiency of the integrated PBRTQC system over the IQC-only system. These insights can help laboratories make informed decisions on adopting PBRTQC models and provide as evidence for revising regulation on IQC.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry and laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/cclm-2025-0163","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Recent advances in information technology have renewed interest in patient-based real-time quality control (PBRTQC) as an alternative to internal quality control (IQC). However, since regulations mandate IQC, PBRTQC can only be implemented as a separate system. The additional labor required for PBRTQC may hinder widespread adoption. Therefore, a more efficient system that integrates IQC with PBRTQC is needed for laboratories to implement the methods effectively.
Methods: A QC system that integrates IQC with PBRTQC is proposed. The maximum average number of patients with unacceptable analytical errors (MaxANPTE) was introduced as a critical metric to benchmark the efficiency of the integrated PBRTQC system against the IQC-only system using a modified Parvin patient risk model. With the historical data of serum sodium (Na), chloride (Cl), alanine aminotransferase (ALT), and creatinine (CREA) from Zhongshan Hospital, Fudan University, in 2019, the integrated system incorporating the simple PBRTQC model and the more advanced regression-adjusted real-time quality control (RARTQC) were compared with the IQC-only system.
Results: In most cases, the integrated system incorporating RARTQC models outperformed the IQC-only system, particularly for ALT, where QC events were reduced by up to 45 %. Based on these findings, we proposed strategies for laboratories to design the integrated system.
Conclusions: The study demonstrated the improvement of efficiency of the integrated PBRTQC system over the IQC-only system. These insights can help laboratories make informed decisions on adopting PBRTQC models and provide as evidence for revising regulation on IQC.
期刊介绍:
Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor over 3. CCLM is issued monthly, and it is published in print and electronically.
CCLM is the official journal of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and publishes regularly EFLM recommendations and news. CCLM is the official journal of the National Societies from Austria (ÖGLMKC); Belgium (RBSLM); Germany (DGKL); Hungary (MLDT); Ireland (ACBI); Italy (SIBioC); Portugal (SPML); and Slovenia (SZKK); and it is affiliated to AACB (Australia) and SFBC (France).
Topics:
- clinical biochemistry
- clinical genomics and molecular biology
- clinical haematology and coagulation
- clinical immunology and autoimmunity
- clinical microbiology
- drug monitoring and analysis
- evaluation of diagnostic biomarkers
- disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes)
- new reagents, instrumentation and technologies
- new methodologies
- reference materials and methods
- reference values and decision limits
- quality and safety in laboratory medicine
- translational laboratory medicine
- clinical metrology
Follow @cclm_degruyter on Twitter!